| (2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B. |
|
Patent |
|
| (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A. |
|
Patent |
|
| (2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A. |
|
Patent |
|
| (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A. |
|
Patent |
|
| (2021). ANTIBODY. Patent Number: PT3311170T. |
|
Patent |
|
| (2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0. |
|
Patent |
|
| (2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T. |
|
Patent |
|
| (2021). MODELING TEST. Patent Number: PT3311169T. |
|
Patent |
|
| (2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T. |
|
Patent |
|
| (2022). ANTIBODY EPITOPE. Patent Number: PT3311171T. |
|
Patent |
|
| (2020). ANTI-BCMA ANTIBODIES, BIESPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND THEIR USES. Patent Number: PT3337824T. |
|
Patent |
|
| (2021). Sixty‐Seventh Annual Scientific Meeting of Canadian Organization of Medical Physicists. Medical Physics 48(8) , 4666-4666. 10.1002/mp.15102. |
BMIT-ID |
Conference Proceeding |
Materials |
| (2020). Scientific Abstracts and Sessions. Medical Physics 47(6) , E702-E702. 10.1002/mp.14316. |
BMIT-ID |
Conference Proceeding |
Materials |
| 호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 요한 프란손; 로빈 매튜 할렛; 모니카 파스쿠알 가르시아 et al. (2021). Combination of LIF inhibitor and PD-1 axis inhibitor for use in treating cancer. Patent Number: KR20210021287A. |
|
Patent |
|
| 호안 세오안 수아레즈; 후디트 아니도 폴구에이라; 로빈 매튜 홀레트; 파트리샤 앤 깁린; 잔느 마그람 et al. (2021). Combination of LIF inhibitors and platinum-based anti-neoplastic agents for use in treating cancer. Patent Number: KR20210022065A. |
|
Patent |
|